The KEMRI-Wellcome Trust Research Programme was set up in 1989 with a primary focus on malaria research. Over the years the research programme has expanded and conducts wide-ranging research in various disciplines;
The PCVI Study
This includes Pneumococcal Conjugate Vaccine Impact Study which was launched in collaboration with the Ministry of Health in 2008 in preparation for the introduction of the Pneumococcal Conjugate Vaccine (PCV-10) in 2011.
PCVIS is funded by Gavi, the Vaccine Alliance. The main objective of this study is to assess the impact of introducing PCV-10 into the Expanded Programme of Immunization schedule in Kenya and to determine its cost-effectiveness. Following 4 years after introduction of PCV-10, KWTRP and the Ministry of Health are now in a position to share results with partners, funders and other stakeholders. Find more information on http://www.pcvis.org/
The School Engagement Program
We have several ways in which we discuss research with the community at the KEMRI-Wellcome Trust Research Programme in Kilifi. These include meetings with community members, health workers and community leaders.
A new approach involves activities with local secondary schools. Since 2008, we have been working closely with the County Education Office, local students and science teachers to establish the KEMRI Schools Engagement Programme (SEP).
SEP was established for three reasons: first, to respond to the local leaders’ requests for involvement in schools; second, because researchers felt that they could contribute to local secondary school education; and third, to create an opportunity for dialogue between researchers and members of the community aimed at promoting mutual understanding.Find more information on http://sep.kemri-wellcome.org/index.php/front/
